Breaking News

Cryoport Systems Secures ISO Certification for Cell Therapy Transport Standards

The certification highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain.

Author Image

By: Charlie Sternberg

Associate Editor

Cryoport Systems, a subsidiary of Cryoport Inc., has received certification under ISO 21973:2020, the international standard governing the transportation of human cells intended for therapeutic use. The certification, issued by the International Organization for Standardization (ISO), highlights the company’s adherence to rigorous safety and traceability protocols within the cell and gene therapy supply chain. Cryoport Systems was actively involved in the development of the ISO 21973 standard...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters